AbbVie, Inc. (ABBV)
224.81
+0.46
(+0.20%)
USD |
NYSE |
Feb 20, 16:00
224.87
+0.06
(+0.03%)
After-Hours: 20:00
AbbVie SG&A Expense (Quarterly) : 3.895B for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Amgen, Inc. | 1.952B |
| Biogen, Inc. | 682.50M |
| Gilead Sciences, Inc. | 1.794B |
| Johnson & Johnson | 6.753B |
| Eli Lilly & Co. | 3.132B |